<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17610</article-id><article-id pub-id-type="doi">10.46235/1028-7221-17610-PIT</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Population immunity to diphtheria and pertussis in the communities of St. Petersburg and Leningrad Region</article-title><trans-title-group xml:lang="ru"><trans-title>Популяционный иммунитет к возбудителям дифтерии и коклюша у населения Санкт-Петербурга и Ленинградской области</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Drobyshevskaia</surname><given-names>V. G.</given-names></name><name xml:lang="ru"><surname>Дробышевская</surname><given-names>В. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач клинической лабораторной диагностики, заведующая Центральной клинико-диагностической лабораторией; преподаватель кафедры иммунологии</p></bio><bio xml:lang="en"><p>Doctor in Clinical and Laboratory Diagnostics, Head, Central Clinical Diagnostic Laboratory; Lecturer, Department of Immunology</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Смирнов</surname><given-names>В. С.</given-names></name><name xml:lang="en"><surname>Smirnov</surname><given-names>V. S.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., профессор, ведущий научный сотрудник лаборатории молекулярной иммунологии</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Leading Researcher, Laboratory of Molecular Immunology</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Егорова</surname><given-names>С. А.</given-names></name><name xml:lang="en"><surname>Egorova</surname><given-names>S. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., заместитель директора по инновациям</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Deputy Director for Innovation</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Буц</surname><given-names>Л. В.</given-names></name><name xml:lang="en"><surname>Buts</surname><given-names>L. V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач-эпидемиолог</p></bio><bio xml:lang="en"><p>Epidemiologist</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Жимбаева</surname><given-names>О. Б.</given-names></name><name xml:lang="en"><surname>Zhimbaeva</surname><given-names>O. B.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач клинической лабораторной диагностики, заведующая лабораторией молекулярно-генетической диагностики</p></bio><bio xml:lang="en"><p>Doctor in Clinical and Laboratory Diagnostics, Head, Laboratory of Molecular Genetic Diagnostics</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Кокорина</surname><given-names>Г. И.</given-names></name><name xml:lang="en"><surname>Kokorina</surname><given-names>G. I.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>старший научный сотрудник лаборатории медицинской бактериологии</p></bio><bio xml:lang="en"><p>Senior Researcher, Laboratory of Medical Bacteriology</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Сварваль</surname><given-names>А. В.</given-names></name><name xml:lang="en"><surname>Svarval</surname><given-names>A. V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник лаборатории идентификации патогенов</p></bio><bio xml:lang="en"><p>PhD (Medicine), Senior Researcher, Pathogen Identification Laboratory</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Сужаева</surname><given-names>Л. В.</given-names></name><name xml:lang="en"><surname>Suzhaeva</surname><given-names>L. V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>младший научный сотрудник лаборатории идентификации патогенов</p></bio><bio xml:lang="en"><p>Junior Researcher, Pathogen Identification Laboratory</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Фролова</surname><given-names>К. А.</given-names></name><name xml:lang="en"><surname>Frolova</surname><given-names>K. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>лаборант-исследователь лаборатории медицинской бактериологии</p></bio><bio xml:lang="en"><p>Research Assistant, Laboratory of Medical Bacteriology</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Горбунов</surname><given-names>Н. П.</given-names></name><name xml:lang="en"><surname>Gorbunov</surname><given-names>N. P.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>младший научный сотрудник лаборатории гибридомных технологий</p></bio><bio xml:lang="en"><p>Junior Researcher, Laboratory of Hybridoma Technologies</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Бурцева</surname><given-names>А. Г.</given-names></name><name xml:lang="en"><surname>Burtseva</surname><given-names>A. G.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher, Laboratory of Hybridoma Technologies</p></bio><bio xml:lang="ru"><p>младший научный сотрудник лаборатории гибридомных технологий</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhakhov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Жахов</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>научный сотрудник лаборатории гибридомных технологий</p></bio><bio xml:lang="en"><p>Researcher, Laboratory of Hybridoma Technologies</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Костевич</surname><given-names>В. А.</given-names></name><name xml:lang="en"><surname>Kostevich</surname><given-names>V. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Senior Researcher, Laboratory of Hybridoma Technologies</p></bio><bio xml:lang="ru"><p>старший научный сотрудник лаборатории гибридомных технологий</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ищенко</surname><given-names>А. М.</given-names></name><name xml:lang="en"><surname>Ischenko</surname><given-names>A. M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>заведующий лабораторией гибридомных технологий</p></bio><bio xml:lang="en"><p>Head, Laboratory of Hybridoma Technologies</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Миличкина</surname><given-names>А. М.</given-names></name><name xml:lang="en"><surname>Milichkina</surname><given-names>A. M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>к.м.н., главный врач медицинского центра</p></bio><bio xml:lang="en"><p>PhD (Medicine), Chief Physician, Medical Center</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Тотолян</surname><given-names>А. А.</given-names></name><name xml:lang="en"><surname>Totolian</surname><given-names>A. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., профессор, академик РАН, директор; заведующий кафедрой иммунологии</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Director; Head, Department of Immunology</p></bio><email>drobyshevskaia@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="ru">ФБУН «Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека</institution></aff><aff><institution xml:lang="en">Saint Petersburg Pasteur Institute</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="ru">ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ</institution></aff><aff><institution xml:lang="en">First St. Petersburg State I. Pavlov Medical University</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-11-01"><day>01</day><month>11</month><year>2026</year></pub-date><pub-date date-type="collection"><year>2026</year></pub-date><volume>29</volume><issue>4</issue><issue-title xml:lang="ru"/><issue-title xml:lang="en"/><fpage>1055</fpage><lpage>1066</lpage><history><date date-type="received" iso-8601-date="2026-08-20"><day>20</day><month>08</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-08-28"><day>28</day><month>08</month><year>2026</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2026-08-20"><day>20</day><month>08</month><year>2026</year></date></event-desc></event><event event-type="accepted"><event-desc>Accepted:<date date-type="accepted" iso-8601-date="2026-08-28"><day>28</day><month>08</month><year>2026</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-11-01"><day>01</day><month>11</month><year>2026</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="ru">Copyright ©; 2026, Дробышевская В.Г., Смирнов В.С., Егорова С.А., Буц Л.В., Жимбаева О.Б., Кокорина Г.И., Сварваль А.В., Сужаева Л.В., Фролова К.А., Горбунов Н.П., Бурцева А.Г., Жахов А.В., Костевич В.А., Ищенко А.М., Миличкина А.М., Тотолян А.А.</copyright-statement><copyright-statement xml:lang="en">Copyright ©; 2026, Drobyshevskaia V.G., Smirnov V.S., Egorova S.A., Buts L.V., Zhimbaeva O.B., Kokorina G.I., Svarval A.V., Suzhaeva L.V., Frolova K.A., Gorbunov N.P., Burtseva A.G., Zhakhov A.V., Kostevich V.A., Ischenko A.M., Milichkina A.M., Totolian A.A.</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Дробышевская В.Г., Смирнов В.С., Егорова С.А., Буц Л.В., Жимбаева О.Б., Кокорина Г.И., Сварваль А.В., Сужаева Л.В., Фролова К.А., Горбунов Н.П., Бурцева А.Г., Жахов А.В., Костевич В.А., Ищенко А.М., Миличкина А.М., Тотолян А.А.</copyright-holder><copyright-holder xml:lang="en">Drobyshevskaia V.G., Smirnov V.S., Egorova S.A., Buts L.V., Zhimbaeva O.B., Kokorina G.I., Svarval A.V., Suzhaeva L.V., Frolova K.A., Gorbunov N.P., Burtseva A.G., Zhakhov A.V., Kostevich V.A., Ischenko A.M., Milichkina A.M., Totolian A.A.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/17610">https://rusimmun.ru/jour/article/view/17610</self-uri><abstract xml:lang="en"><p>Diphtheria and pertussis are characterized by severe complications and high contagiousness, still remaining significant vaccine-preventable infections. Despite routine immunization, decline of specific immunity creates susceptible groups among adolescents and adults. The aim of this study was to assess population immunity to diphtheria and whooping cough pathogens in the population of St. Petersburg and Leningrad Region. The study included 6,774 individuals in 2023 and 3,524 individuals in 2025, aged 1 year to 70+ years. Participants completed a questionnaire, and provided venous blood samples in order to determine IgG antibodies to diphtheria and pertussis using ELISA test systems manufactured by the Pasteur Research Institute of Epidemiology and Microbiology. Statistical analysis was performed using the Excel package. The average seroprevalence for diphtheria was 92.1% in St. Petersburg and 93.2% in Leningrad Region. In both regions, individuals with basic protection (0.1-1.0 IU/mL) predominated. The proportion of individuals with a high level of long-term protection (&gt; 1.5 IU/mL) was highest in the 1-11 year old group (&gt; 13%), but decreased in adolescents due to fading immunity. In adult cohorts, overall seroprevalence was maximal in the 30-39 year old groups in the City (97.7%), and 40-49 year olds in the Leningrad region (96.6%). In the non-vaccinated residents of the Leningrad region, an abnormally high levels of antibodies (92.1%) were detected, being close to the values registered among vaccinated individuals (93.7%), thus suggesting latent boosterization. Individuals over 60 years of age are the least protected. The level of population immunity to diphtheria required in the Russian Federation (95% in children, 90% in adults) was achieved only in children aged 1-5 years for the Leningrad Region, and in adults under 60 years in both regions. The obtained data show a predominance of individuals with the level of specific IgG antibodies to pertussis toxin &lt; 40 IU/mL, thus suggesting the absence of immune protection in a significant proportion of those examined (the average seroprevalence to pertussis was 7.3% in St. Petersburg and 9.8% in the Leningrad Region). In the context of the epidemiological situation with pertussis in St. Petersburg and the Leningrad Region, this finding indicates the emergence of a significant susceptible cohort and confirms the need to revise the vaccination strategy to include additional booster vaccinations in older age groups. The transition to digital vaccination reports is a significant step toward ensuring sustainable population immunity. An integrated registration platform would help objective verification of medical histories and minimize the risk of developing localized areas of protection deficiency.</p></abstract><trans-abstract xml:lang="ru"><p>Дифтерия и коклюш, характеризующиеся тяжелыми осложнениями и высокой контагиозностью, остаются значимыми вакциноуправляемыми инфекциями. Несмотря на плановую иммунизацию, угасание иммунитета формирует восприимчивые группы среди подростков и взрослых. Целью исследования явилась оценка популяционного иммунитета к возбудителям дифтерии и коклюша у населения Санкт-Петербурга и Ленинградской области. В исследовании участвовали 6774 человек в 2023 году и 3524 человека в 2025 году в возрасте от 1-го года до 70+ лет. В ходе исследования участники заполняли анкету и сдавали пробы венозной крови для определения IgG-антител к токсинам возбудителей дифтерии и коклюша методом ИФА с использованием тест-систем производства ФБУН НИИЭМ им. Пастера. Статистический анализ выполнен методами вариационной статистики с использованием пакета Excel. Средняя серопревалентность к дифтерии составила 92,1% в Санкт-Петербурге и 93,2% в Ленинградской области. В обоих регионах преобладали лица с базовой защитой (0,1-1,0 МЕ/мл). Доля лиц с высоким уровнем долгосрочной защиты (&gt; 1,5 МЕ/мл) максимальна в группе 1-11 лет (&gt; 13%), но снижается у подростков. В зрелом возрасте максимальная серопревалентность отмечена в группах 30-39 лет в городе (97,7%) и 40-49 лет в области (96,6%). У непривитых неболевших жителей области выявлен высокий уровень антител (92,1%), близкий к вакцинированным (93,7%), что может быть обусловлено естественной латентной бустеризацией. Наименее защищены лица старше 60 лет. Регламентированный в РФ уровень популяционного иммунитета к дифтерии (95% у детей, 90% у взрослых) достигнут лишь у детей 1-5 лет в Ленинградской области и у взрослых до 60 лет в обоих регионах. У большинства обследованных специфические IgG-антитела к коклюшному токсину отсутствовали (уровень менее 40 МЕ/мл), средняя серопревалентность составила 7,3% в Санкт-Петербурге и 9,8% в Ленинградской области. Это свидетельствует о незначительной прослойке лиц, имеющих напряженный постинфекционный или поствакцинальный иммунитет после вакцинации бесклеточными вакцинами. Переход на цифровой формат учета прививок является значимым шагом к обеспечению устойчивого популяционного иммунитета. Единая регистрационная платформа поможет объективно верифицировать анамнез и своевременно выявлять территории и группы населения с недостаточным уровнем иммунной защиты.</p></trans-abstract><kwd-group xml:lang="en"><kwd>vaccination-preventable infections</kwd><kwd>diphtheria</kwd><kwd>pertussis</kwd><kwd>population immunity</kwd><kwd>post-vaccination immunity</kwd><kwd>seroprevalence</kwd><kwd>vaccination</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вакциноуправляемые инфекции</kwd><kwd>дифтерия</kwd><kwd>коклюш</kwd><kwd>популяционный иммунитет</kwd><kwd>поствакцинальный иммунитет</kwd><kwd>серопревалентность</kwd><kwd>вакцинация</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>МУ 3.1.2943-11. Организация и проведение серологического мониторинга состояния коллективного иммунитета к инфекциям, управляемым средствами специфической профилактики (дифтерия, столбняк, коклюш, корь, краснуха, эпидемический паротит): Методические указания [Электронный ресурс]. М.: Федеральный центр гигиены и эпидемиологии Роспотребнадзора, 2011. 27 с. Режим доступа: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=4852 (дата обращения: 04.04.2026). [Methodological Guidelines MU 3.1.2943-11. Organization and conduct of serological monitoring of the state of collective immunity to infections controlled by means of specific prophylaxis (diphtheria, tetanus, pertussis, measles, rubella, mumps) [Electronic resource]. Moscow: Federal Center of Hygiene and Epidemiology of Rospotrebnadzor, 2011. 27 p. Available at: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=4852 (date of access: Аpril 4, 2026)].</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Харит С.М., Иозефович О.В., Фридман И.В. Вакцинопрофилактика коклюша: проблемы, возможные решения // Журнал инфектологии, 2020. Т. 12, № 2. С. 50-57. [Kharit S.M., Iozefovich O.V., Fridman I.V. Vaccinal prevention of pertussis: problems and possible solutions. Zhurnal infektologii = Journal of Infectology, 2020, Vol. 12, no. 2, pp. 50-57. (In Russ.)]</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Bricks L.F., Vargas-Zambrano J.C., Macina D. Epidemiology of Pertussis After the COVID-19 Pandemic: Analysis of the Factors Involved in the Resurgence of the Disease in High-, Middle-, and Low-Income Countries. Vaccines, 2024, Vol. 12, no. 12, 1346. doi: 10.3390/vaccines12121346.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Christie C.D. Resurgence of pertussis: whopping the ‘100-day cough’. Curr. Opin. Pediatr., 2025, Vol. 37, no. 5, pp. 508-516.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>European Centre for Disease Prevention and Control. Laboratory diagnosis and molecular surveillance of Bordetella pertussis. Stockholm: ECDC, 2026. Available at: https://www.ecdc.europa.eu/en/publications-data/bordetella-pertussis-laboratory-diagnosis-and-molecular-surveillance.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Global Diphtheria Trends and Regional Disparities. Open Public Health J., 2025, Vol. 18, e18749445428365. Available at: https://openpublichealthjournal.com/VOLUME/18/ELOCATOR/e18749445428365/PDF/.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kitamura N., Bahkali K., Chem E.D., Quilty B.J., Edwards T., Toizumi M., Yoshida L.M. Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis. Hum. Vaccin. Immunother., 2022, Vol. 18, no. 6, 2099700. doi: 10.1080/21645515.2022.2099700.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kretzschmar M., Teunis P.F., Pebody R.G. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med., 2010, Vol. 7, no. 6, e1000291. doi: 10.1371/journal.pmed.1000291.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>McGirr A., Fisman D.N. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics, 2015, Vol. 135, no. 1, pp. 98-107.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>National surveillance systems “WHO/UNICEF Joint Reporting Form on Immunization (JRF) 2015-2025”. Geneva: World Health Organization, 2025. Available at: https://immunizationdata.who.int/.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Popova A.Yu., Egorova S.A., Smirnov V.S., Ezhlova E.B., Milichkina A.M., Melnikova A.A., Bashketova N.S., Istorik O.A., Buts L.V., Ramsay E.S., Drozd I.V., Zhimbaeva O.B., Drobyshevskaya V.G., Danilova E.M., Ivanov V.A., Totolian A.A. Herd immunity to vaccine preventable infections in Saint Petersburg and the Leningrad region: serological status of measles, mumps, and rubella. Russian Journal of Infection and Immunity, 2024, Vol. 14, no. 6, pp. 1187-1208. doi: 10.15789/2220-7619-HIT-17797.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Smet J., Smits K., Dirix V., Vermeulen F., de Schutter I., Buisman A.M., Corbière V., Locht C., Mascart F. Multiparametric analysis of vaccine-induced B and T cell responses for optimal evaluation of memory immune responses to Bordetella pertussis in children. Vaccine, 2026, Vol. 81, 128552. doi: 10.1016/j.vaccine.2026.128552.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Truelove S.A. Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis. Clin. Infect. Dis., 2020, Vol. 71, no. 1, pp. 89-97.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wilkinson K., Righolt C.H., Elliott L.J., Fanella S., Mahmud S.M. Pertussis vaccine effectiveness and duration of protection– a systematic review and meta-analysis. Vaccine, 2021, Vol. 39, no. 23, pp. 3120-3130.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>World Health Organization. WHO laboratory manual for the diagnosis of diphtheria and other related infections (Laboratory manuals). Geneva: World Health Organization, 2021. Available at: https://iris.who.int/items/22bea5d3-1ee5-40f0-97db-65a389c4e397.</mixed-citation></ref></ref-list></back></article>
